$2.6M grant funds biosensor project for COPD exacerbation monitoring

Summary: The Lundquist Institute receives a $2,623,234 grant from USAMRAA for a four-year project led by Dr. Harry Rossiter to develop wearable biosensors for COPD exacerbation risk monitoring. COPD affects 16 million Americans and is the third leading global cause of death. The biosensor, analyzing inflammatory molecules in sweat, aims to predict acute exacerbations early, potentially reducing patient morbidity and healthcare costs. Collaboration with Caltech enhances medical technology for chronic disease management.

Full article